These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38388139)

  • 1. Mining the amyloid-plaque proteome to uncover disease mechanisms in renal amyloidoses.
    Nuvolone M; Merlini G
    Kidney Int; 2024 Mar; 105(3):427-429. PubMed ID: 38388139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteome profiling provides evidence of an activation of the complement cascade in ATTR amyloidosis.
    Treitz C; Gottwald J; Gericke E; Urban P; Meliß RR; Axmann HD; Siebert F; Becker K; Tholey A; Röcken C
    Amyloid; 2022 Jun; 29(2):102-109. PubMed ID: 34913770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proteomic atlas of kidney amyloidosis provides insights into disease pathogenesis.
    Charalampous C; Dasari S; McPhail E; Theis JD; Vrana JA; Dispenzieri A; Leung N; Muchtar E; Gertz M; Ramirez-Alvarado M; Kourelis T
    Kidney Int; 2024 Mar; 105(3):484-495. PubMed ID: 38096952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
    Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
    Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.
    Lavatelli F; Perlman DH; Spencer B; Prokaeva T; McComb ME; Théberge R; Connors LH; Bellotti V; Seldin DC; Merlini G; Skinner M; Costello CE
    Mol Cell Proteomics; 2008 Aug; 7(8):1570-83. PubMed ID: 18474516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology and diagnosis of renal non-AL amyloidosis.
    Sethi S; Theis JD
    J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration.
    D'Souza A; Theis JD; Vrana JA; Dogan A
    Amyloid; 2014 Jun; 21(2):71-5. PubMed ID: 24446896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pathology of Amyloidosis in Classification: A Review.
    Picken MM
    Acta Haematol; 2020; 143(4):322-334. PubMed ID: 32392555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
    Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
    BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
    Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
    Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies.
    Noborn F; Thomsen C; Vorontsov E; Bobbio E; Sihlbom C; Nilsson J; Polte CL; Bollano E; Vukusic K; Sandstedt J; Dellgren G; Karason K; Oldfors A; Larson G
    Amyloid; 2023 Mar; 30(1):96-108. PubMed ID: 36209425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis.
    Dasari S; Amin MS; Kurtin PJ; Vrana JA; Theis JD; Grogg KL; Alexander MP; Nasr SH; Fervenza FC; Leung N; Sethi S
    Kidney Int; 2016 Sep; 90(3):658-64. PubMed ID: 27262366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis shows that the main constituent of subepidermal localised cutaneous amyloidosis is not galectin-7.
    Chapman JR; Liu A; Yi SS; Hernandez E; Ritorto MS; Jungbluth AA; Pulitzer M; Dogan A
    Amyloid; 2021 Mar; 28(1):35-41. PubMed ID: 32867548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.
    Leung N; Nasr SH; Sethi S
    Blood; 2012 Oct; 120(16):3206-13. PubMed ID: 22948045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in tissue proteome associated with ATTR amyloidosis: insights into pathogenesis.
    Brambilla F; Lavatelli F; Valentini V; Di Silvestre D; Obici L; Mauri P; Merlini G
    Amyloid; 2012 Jun; 19 Suppl 1():11-3. PubMed ID: 22551153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic typing of amyloid deposits in systemic amyloidoses.
    Lavatelli F; Vrana JA
    Amyloid; 2011 Dec; 18(4):177-82. PubMed ID: 22080761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amyloid proteome: a systematic review and proposal of a protein classification system.
    Gottwald J; Röcken C
    Crit Rev Biochem Mol Biol; 2021 Oct; 56(5):526-542. PubMed ID: 34311636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics with Mass Spectrometry Imaging: Beyond Amyloid Typing.
    Lavatelli F; Merlini G
    Proteomics; 2018 Apr; 18(7):e1700353. PubMed ID: 29389069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits.
    Winter M; Tholey A; Krüger S; Schmidt H; Röcken C
    J Histochem Cytochem; 2015 Oct; 63(10):772-9. PubMed ID: 26101327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amyloid Registry Kiel : An interim balance].
    Röcken C
    Pathologe; 2018 Dec; 39(Suppl 2):301-305. PubMed ID: 30302563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.